Lumisys issues warning on second-quarter results
Lumisys issues warning on second-quarter resultsFilm digitizer firm Lumisys warned that its second-quarter bookings have not been as strong as anticipated, and the firm will have lower revenues during its second quarter. It is expected that
Lumisys issues warning on second-quarter results
Film digitizer firm Lumisys warned that its second-quarter bookings have not been as strong as anticipated, and the firm will have lower revenues during its second quarter. It is expected that earnings, scheduled for release after the market closes on July 9, will be break-even to slightly positive for the period, said Craig Klosterman, COO and CFO.
Continuing to believe its stock is undervalued, the Lumisys board of directors has authorized an additional repurchase of 500,000 shares of its common stock. Lumisys repurchased 350,000 shares of common stock during the second quarter as part of an earlier stock buyback program.
In product news, Lumisys has released DICOM-compatible interface software, which can be incorporated across the company's entire family of Lumiscan film digitizers. The Windows NT-based interface, called DI-2000, generates DICOM 3.0 output of images, and provides support for DICOM 3.0 storage class user, storage class provider, and query/retrieve. It also supports lossless, lossy, and enhanced JPEG compression, as well as image transmission over a local area network, wide area network, or the Internet, according to the company. Royalty-free software will be provided to all trained and certified integrators and OEMs incorporating Lumisys digitizers into PACS and teleradiology networks, according to the Sunnyvale, CA-based company.
- Search again
- Homepage
Can MRI-Guided Transurethral Ultrasound Ablation Have an Impact for Localized Prostate Cancer?
December 11th 2023Follow-up MRI imaging one year after transurethral ultrasound ablation revealed approximately 50 percent decreases in prostate volume and median PSA density, according to recently presented research findings at the 2023 Society of Urologic Oncology (SUO) Annual Meeting.
What a New Mammography Study Reveals About BMI, Race, Ethnicity and Advanced Breast Cancer Risk
December 8th 2023In a new study examining population attributable risk proportions (PARPs) based on data from over three million screening mammography exams, researchers found that postmenopausal Black women had the highest BMI-related PARP and premenopausal Asian and Pacific Islander women had the highest breast density-related PARP for advanced breast cancer.
Study: Contrast-Enhanced Mammography Changes Surgical Plan in 22.5 Percent of Breast Cancer Cases
December 7th 2023Contrast-enhanced mammography detected additional lesions in 43 percent of patients and led to additional biopsies in 18.2 percent of patients, over half of whom had malignant lesions, according to a study of over 500 women presented at the recent Radiological Society of North America (RSNA) conference.
What a New Study Reveals About Adjunctive DBT and Early-Stage Invasive Breast Cancer
December 6th 2023The combination of digital breast tomosynthesis (DBT) and digital mammography had a 21.6 higher invasive breast cancer detection rate for stage 1 tumors than digital mammography alone, according to a new study involving nearly 100,000 women.
